Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 51, 2016 - Issue 3
Submit an article Journal homepage
1,159
Views
12
CrossRef citations to date
0
Altmetric
Liver and biliary tract

Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience

Jesper WaldenströmDepartment of Infectious Medicine/Virology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden;
,
Martti FärkkiläClinic of Gastroenterology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland;
,
Karolina RembeckDepartment of Infectious Medicine/Virology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden;
,
Gunnar NorkransDepartment of Infectious Medicine/Virology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden;
,
Nina LangelandDepartment of Clinical Science, University of Bergen, Bergen, Norway; ;Department of Medicine, Haukeland University Hospital, Bergen, Norway;
,
Kristine MørchDepartment of Medicine, Haukeland University Hospital, Bergen, Norway;
,
Court PedersenDepartment of Infectious Diseases, University of Southern Denmark, Odense, Denmark;
,
Mads Rauning BuhlDepartment of Infectious Diseases, Aarhus University, Aarhus, Denmark;
,
Urpo NieminenClinic of Gastroenterology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland;
,
Hannu NuutinenClinic of Gastroenterology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland;
,
Åsa AlsiöInfektion, Skaraborgs Sjukhus Skövde, Skövde, Sweden;
,
Lars HolmströmInfektionskliniken, Hallands sjukhus, Halmstad, Sweden;
,
Rolf JungneliusInfektionskliniken, Södra Älvsborgs Sjukhus, Borås, Sweden;
,
Katarina LundInfektionskliniken, NÄL, Trollhättan, Sweden;
,
Anders RubenssonInfektionskliniken, Centralsjukhuset, Karlstad, Sweden
,
Erik TorellInfektionskliniken, Gävle Sjukhus, Gävle, Sweden
,
Johan WestinDepartment of Infectious Medicine/Virology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden;
&
Martin LaggingDepartment of Infectious Medicine/Virology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden; Correspondence[email protected]
 show all
Pages 337-343 | Received 17 Apr 2015, Accepted 22 Aug 2015, Published online: 29 Sep 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Martin Lagging, Rune Wejstål, Ann-Sofi Duberg, Soo Aleman, Ola Weiland & Johan Westin. (2018) Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017. Infectious Diseases 50:8, pages 569-583.
Read now
Martin Lagging, Rune Wejstål, Gunnar Norkrans, Olle Karlström, Soo Aleman, Ola Weiland, Maria Castedal & Johan Westin. (2017) Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016. Infectious Diseases 49:8, pages 561-575.
Read now
Martin Lagging, Rune Wejstål, Gunnar Norkrans, Olle Karlström, Soo Aleman, Ola Weiland, Maria Castedal & Filip Josephson. (2016) Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations. Infectious Diseases 48:4, pages 251-261.
Read now

Articles from other publishers (9)

Mariantonietta Di Stefano, Mona H. Ismail, Thomas Leitner, Giuseppina Faleo, Marwan Jabr Alwazzeh, Jean Lutamyo Mbisa, Josè Ramon Fiore & Teresa Antonia Santantonio. (2023) A novel candidate hepatitis C virus genotype 4 subtype identified by next generation sequencing full-genome characterization in a patient from Saudi Arabia. Frontiers in Microbiology 14.
Crossref
George D Liatsos. (2021) Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages. World Journal of Clinical Cases 9:19, pages 5135-5178.
Crossref
Kristina Nyström, Jesper Waldenström, Ka-Wei Tang & Martin Lagging. (2019) Ribavirin: pharmacology, multiple modes of action and possible future perspectives. Future Virology 14:3, pages 153-160.
Crossref
E. A. Nurmukhametova, N. P. Blokhina & S. V. Smetanina. (2019) Organization of medical care and drug provision for patients with chronic hepatitis C in Moscow. Dokazatel'naya gastroenterologiya 8:1, pages 84.
Crossref
Kristina Nyström, Paulina H. Wanrooij, Jesper Waldenström, Ludmila Adamek, Sofia Brunet, Joanna Said, Staffan Nilsson, Megan Wind-Rotolo, Kristoffer Hellstrand, Helene Norder, Ka-Wei Tang & Martin Lagging. (2018) Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus. Journal of Virology 92:19.
Crossref
Yanhua Li, Jiuping Wang, Juan Wang, Yunfeng Xiao, Bin Xu, Hongwei Li, Liu Yang, Xiaoke Hao & Yueyun Ma. (2017) SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China. Virology Journal 14:1.
Crossref
Shao-Ru Chen, An-Qi Wang, Li-Gen Lin, Hong-Cong Qiu, Yi-Tao Wang & Ying Wang. (2016) In Vitro Study on Anti-Hepatitis C Virus Activity of Spatholobus suberectus Dunn. Molecules 21:10, pages 1367.
Crossref
Federico Sáez‐Royuela & Ester Badia. (2016) Sofosbuvir plus ribavirin in Asian patients with chronic genotype 2 hepatitis C virus infection: history of a success?. Liver International 36:8, pages 1093-1095.
Crossref
N. D. Yushchuk, O. O. Znoyko, K. R. Dudina, A. N. Kozina & O. V. Kalininа. (2016) The efficiency of antiviral therapy in patients with chronic hepatitis C infected with hepatitis C virus recombinants. Terapevticheskii arkhiv 88:6, pages 101.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.